Pulsed heart ablation vs fake procedure for irregular heartbeat
Part of Heart & circulation clinical trials.
This trial tests whether pulsed-field ablation (a targeted treatment meant to stop abnormal heart signals) works better than a sham, or “placebo,” ablation. It is for certain people with atrial fibrillation (AF) to see if symptoms and heart rhythm outcomes improve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re older than 18 years
- You have paroxysmal or persistent AF that is not long-term/persistent for over a year
- Your AF symptom score (AFEQT) is 50 or lower
- You have not had prior AF ablation or left-atrial ablation
- Recent heart rhythm checks show AF lasting over 30 seconds within the last 6 months
- Your heart structure/health meets key safety limits (left atrium size, heart strength, valve and lung pressure limits)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
This trial tests a new type of heart procedure called pulsed field ablation to treat an irregular heartbeat (atrial fibrillation) in people who have already had a device placed to close off a part of the heart (left atrial appendage occlusion). The goal is to see if this safer ablation method can help control your heart rhythm.
This study tests advanced technology to improve how atrial fibrillation (AFib) is treated with a heart ablation procedure. It may help patients who are already advised to have AFib ablation by seeing how well the approach works in real clinical practice.
This study tests a newer ablation technique using pulsed electrical energy to treat atrial fibrillation (an irregular heartbeat). You may qualify if you were recently diagnosed with AF and haven't had ablation before.
This trial tests a new way to treat non-paroxysmal atrial fibrillation (AF) using a focused type of ablation (pulsed-field energy) on specific areas of the heart. It aims to see if targeting the left atrial wall and mitral isthmus can improve outcomes for people who have not had this procedure before.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.